A Retrospective Observational Study to Determine Baseline Characteristics and Early Prescribing Patterns for Patients Receiving Alirocumab in UK Clinical Practice.

Reynolds, Tim; Carey, Peter; George, Jacob; Konidaris, Gerasimos; Narayanan, Deepa; Ramachandran, Sudarshan; Saunders, Luke; Viljoen, Adie; Ferns, Gordon

Reynolds, Tim; Carey, Peter; George, Jacob; Konidaris, Gerasimos; Narayanan, Deepa; Ramachandran, Sudarshan; Saunders, Luke; Viljoen, Adie; Ferns, Gordon.

Afiliação

Reynolds T; Queen's Hospital, Burton-on-Trent, UK.
Carey P; Sunderland Royal Hospital, Sunderland, UK.
George J; Ninewells Hospital, Dundee, UK.
Konidaris G; Sanofi UK, Guilford, UK.
Narayanan D; Hull and East Yorkshire Hospitals NHS Trust, Hull, UK.
Ramachandran S; Good Hope Hospital/Birmingham Heartlands Hospital, Sutton Coldfield, UK.
Saunders L; OPEN VIE, Marlow, England, UK.
Viljoen A; Lister Hospital, Stevenage, UK.
Ferns G; Brighton and Sussex University Hospital, Brighton, BN1 9PX, UK. G.Ferns@bsms.ac.uk.

Drugs Real World Outcomes ; 6(4): 205-213, 2019 Dec.

Article em En | MEDLINE | ID: mdl-31741198

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Clinical_trials / Guideline / Health_technology_assessment / Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google